| Therapeutic
Category: Antilipemic Agent, Fibric Acid
Use: Adjunct to
diet therapy for the treatment of adults with very high elevations of serum
triglyceride levels (types IV and V hyperlipidemia) who are at risk of
pancreatitis and who do not respond adequately to a determined dietary
effort.
Contraindications:
Hypersensitivity to fenofibrate or any component of the formulation, hepatic
or severe renal dysfunction including primary biliary cirrhosis and unexplained
liver function abnormalities; pre-existing gallbladder disease. Patients
should avoid alcohol.
Adverse Reactions:
abdominal pain, constipation, abnormal liver function tests, creatine phosphokinase
increased, cholecystitis, cholelithiasis, gastritis, vomiting, hypoglycemia,
and kidney function abnormalities.
|
|
|
|
Mechanism
of Action: TriCor is believed to increase very low-density lipoprotein
cholesterol (VLDL) catabolism by enhancing the synthesis of lipoprotein
lipase; as a result of a decrease in VLDL levels, total plasma triglycerides
are reduced by 30-60%.
Pharmacodynamics:
Absorption: 60-90%
when given with meals.
Distribution:
Widely to most tissues except brain or eye; concentrates in liver, kidneys,
and gut.
Protein Binding: >99%
Metabolism: Metabolized
to its active form, fenofibric acid, by tissue and plasma esterases.
Time to Peak: 4-6 hours
Excretion: Urine
(60-93% metabolites); feces (5-25%).
Nutrition: Take
with food to increase absorption and decrease gastrointestinal distress.
Administration:
6-8 weeks of therapy is required to determine efficacy.
Monitoring Parameters:
Total
serum cholesterol and triglyceride concentration, low-density lipoprotein
cholesterol (LDL), and high-density lipoprotein cholesterol (HDL) levels
should be monitored periodically. Serum transaminases should be monitored
every 3 months.
Dosage Forms: Capsule-
67 mg Tablet- 54 mg, 160 mg
Additional Information:
Visit the TriCor Web Site,
which has information on TriCor and cholesterol. The web site offers
a one-page information sheet called 10 Quick Facts About Cholesterol Management
and a brochure called Keeping Track of Your Cholesterol and Triglycerides.
|
|
|